NDT Advance Access published online on October 11, 2006
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfl566
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Nephrology, Department of Medicine, Jichi Medical School, 3311-1 Yakushiji, Shimotsuke-city, Tochigi 329-0498, Japan
* To whom correspondence should be addressed. Background. Long-term peritoneal dialysis (PD) leads to peritoneal injury. At worst, peritoneal injury leads to encapsulating peritoneal sclerosis (EPS), which is a serious complication of PD. The mortality rate of EPS is extremely high. To perform PD safely, monitoring of peritoneal injury that leads to EPS is a necessity. Methods. A total of 444 PD patients with end-stage renal disease at 60 centres in Japan were analysed (sex, 54% males; median age, 56 years; median PD duration, 55 months). Matrix metalloproteinase (MMP)-2 and MMP-9 in the peritoneal effluents were analysed with gelatin zymography or enzyme-linked immunosorbent assay. Cells expressing MMP-2 in the peritoneal tissue were investigated immunohistologically with anti-MMP-2 antibodies. Peritoneal solute transport was assessed with the peritoneal equilibration test (PET). Results. The MMP-2 levels in peritoneal effluents obtained with the PET were significantly correlated with the D/P Cr ratio (R = 0.69, P < 0.001) and the D/D0 glucose ratio (R = -0.59, P < 0.001). The MMP-2 levels in patients with mild peritoneal injury, moderate peritoneal injury, severe peritoneal injury (EPS) and infectious peritonitis were significantly higher than those in control patients (P < 0.001, P < 0.001, P < 0.01 and P < 0.05, respectively). MMP-2 was produced by myofibroblast-like mesenchymal cells and macrophages in the peritoneum. The peritoneal effluents from patients with infectious peritonitis showed strong MMP-9 signals. Conclusions. From these results, MMP-2 levels in peritoneal effluents reflect peritoneal solute transport and changes in MMP-2 levels are associated with peritoneal injury that leads to EPS. MMP-2 may be a useful marker of peritoneal injury, increased solute transport or progression to EPS.
Received December 26, 2005
Accepted August 29, 2006
Original Article
The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan
Ichiro Hirahara 1 *, Makoto Inoue 1, Kousuke Okuda 1, Yasuhiro Ando 1, Shigeaki Muto 1, and Eiji Kusano 1
Ichiro Hirahara, E-mail: hirahara{at}rpf.jp
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  U. Sen, W. E. Rodriguez, N. Tyagi, M. Kumar, S. Kundu, and S. C. Tyagi Ciglitazone, a PPAR{gamma} agonist, ameliorates diabetic nephropathy in part through homocysteine clearance Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1205 - E1212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-J. Kim, J.-J. Li, K. S. Kim, S.-J. Kwak, D.-S. Jung, D.-R. Ryu, T.-H. Yoo, H. Y. Choi, S. H. Han, H. J. Kim, et al. High glucose decreases collagenase expression and increases TIMP expression in cultured human peritoneal mesothelial cells Nephrol. Dial. Transplant., February 1, 2008; 23(2): 534 - 541. [Abstract] [Full Text] [PDF]
|
|